NAVIGATION
In association with: Register Now
7th November 2017, The Westin Boston Waterfront Hotel

AGENDA

In today’s fast-changing world, to stay competitive means to be innovative and open to embrace new approaches. Industry is facing time-pressing competition when fast movement through exploratory clinical phase is posing great challenges. Early go/no-go decisions have become critical. This is in contrast to dropping efficiency of clinical operations, constantly increasing complexity of study protocols and skyrocketing costs.

Industry thought leaders will gather for a one-day series of round table discussions to exchange their vision of paradigm shifts in early clinical development that are already underway and yet to happen. The focus will be on practical aspects of implementation of innovative approaches to achieve Proof of Concept results in record time. We will share best practices and real-life case studies, exploring them from different perspectives – regulatory, sponsor, clinical site and patient.

Attendees will be able to address these issues and leave the day better informed on how to:

  • Develop an efficient strategy to Proof of Concept ( First-in-Man -> First-in-Patient): classical approach vs. “umbrella” protocols
  • Overcome challenges in execution of exploratory protocols: from feasibility stage to successful patient enrolment in Phase 1b/2a studies. Case studies from oncology, immunology and infectious diseases.
  • Balance scientific/business interests & regulatory requirements
  • Navigate in the new EMA legislation on Phase 1 clinical trials following the incident in France
DOWNLOAD AGENDA

Testimonials

Clinical Operations Strategy Meeting US 2016

Oncology Strategy Meeting Europe 2015 Testimonials

Oncology Strategy Meeting USA East Coast 2016

BIOINFORMATICS Strategy Meeting APAC 2016

Bioinformatics Strategy Meeting Europe 2015

Level of Delegation, Bioinformatics Strategy Meeting USA 2015

Return on Investment, Bioinformatics Strategy Meeting USA 2015

Nathalie Jourdan, President & Owner, Bioptimize

Seth Crosby, Director Partnerships & Alliances, Washington University of Medicine

Jane Yu, Founder & CEO, Ageneo

John Apathy, Senior Advisor Healthcare & Life Sciences, IBM

Dominique Salloum, CEO & Founder, Bioptimize

John Apathy, Bioinformatics Strategy Meetings Europe 2014

Sowmyanarayan Srinivasan, Bioinformatics Strategy Meeting Europe 2014

Oleksandr Otava, Bioinformatics Strategy Meeting Europe 2014

Jerome Wojcik, Bioinformatics Strategy Meeting Europe 2014

Abel Ureta-Vidal, Bioinformatics Strategy Meeting Europe 2014

Roundtable Discussion Format, Bioinformatics Strategy Meeting Europe 2015

Clinical Operations Strategy Meeting US 2016,

Oncology Strategy Meeting Europe 2015 Testimonials

Oncology Strategy Meeting USA East Coast 2016

BIOINFORMATICS Strategy Meeting APAC 2016

Bioinformatics Strategy Meeting Europe 2015

Level of Delegation, Bioinformatics Strategy Meeting USA 2015

Return on Investment, Bioinformatics Strategy Meeting USA 2015

Nathalie Jourdan, President & Owner, Bioptimize

Seth Crosby, Director Partnerships & Alliances, Washington University of Medicine

Jane Yu, Founder & CEO, Ageneo

John Apathy, Senior Advisor Healthcare & Life Sciences, IBM

Dominique Salloum, CEO & Founder, Bioptimize

John Apathy, Bioinformatics Strategy Meetings Europe 2014

Sowmyanarayan Srinivasan, Bioinformatics Strategy Meeting Europe 2014

Oleksandr Otava, Bioinformatics Strategy Meeting Europe 2014

Jerome Wojcik, Bioinformatics Strategy Meeting Europe 2014

Abel Ureta-Vidal, Bioinformatics Strategy Meeting Europe 2014

Roundtable Discussion Format, Bioinformatics Strategy Meeting Europe 2015

Location

The Westin Boston Waterfront 425 Summer Street Boston, MA, 02210 USA
Massachusetts

Date:Nov 07,2017 - Nov 07,2017 Time:09:00AM-5:30PM

Book your seat for the Innovation Spotlight Arensia 2017

Register Now